Archives of Pharmacal Research

, Volume 23, Issue 1, pp 1–16 | Cite as

Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis

  • Ah-Ng Tony Kong
  • Rong Yu
  • Chi Chen
  • Sandhya Mandlekar
  • Thomas Primiano
Review

Abstract

Many natural products elicit diverse pharmacological effects. Using two classes of potential chemopreventive compounds, the phenolic compounds and the isothiocyanates, we review the potential utility of two signaling events, the mitogen-activated protein kinases (MAPKs) and the ICE/Ced-3 proteases (caspases) stimulated by these agents in mammalian cell lines. Studies with phenolic antioxidants (BHA, tBHQ), and natural products (flavonoids; EGCG, ECG, and isothiocyanates; PEITC, sulforaphane), provided important insights into the signaling pathways induced by these compounds. At low concentrations, these chemicals may activate the MAPK (ERK2, JNK1, p38) leading to gene expression of survival genes (c-Fos, c-Jun) and defensive genes (Phase II detoxifying enzymes; GST, QR) resulting in survival and protective mechanisms (homeostasis response). Increasing the concentrations of these compounds will additionally activate the caspase pathway, leading to apoptosis (potential cytotoxicity). Further increment to suprapharmacological concentrations will lead to nonspecific necrotic cell death. The wider and narrow concentration ranges between the activation of MAPK/gene induction and caspases/cell death exhibited by phenolic compounds and isothiocyanates, respectively, in mammalian cells, may reflect their respective therapeutic windowsin vivo. Consequently, the studies of signaling pathways elicited by natural products will advance our understanding of their efficacy and safety, of which many may become important therapeutic drugs of the future.

Key words

MAPK Caspases Chemopreventive agents Phase II drug metabolizing enzymes Apoptosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. NSAIDs may prevent colon cancer through apoptosis, not anti- inflammatory effects [news].Oncology, 10, 624 (1996).Google Scholar
  2. Prevention of cancer in the next millenium: Report of the chemoprevention working group to the American Association for Cancer Research.Cancer Research, 59, 4743–4758 (1999).Google Scholar
  3. Ahmad, N., Feyes, D. K., Nieminen, A. L., Agarwal, R. and Mukhtar, H., Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.J Natl Cancer Inst, 89, 1881–1886 (1997).PubMedCrossRefGoogle Scholar
  4. Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M. and Cook, J. L., Nrf2, a Cap’n’Collar transcription factor, regulates induction of the heme oxygenase-1 gene.J Biol Chem, 274, 26071–26078 (1999).PubMedCrossRefGoogle Scholar
  5. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W. and Yuan, J., Human ICE/CED-3 protease nomenclature [letter].Cell, 87, 171 (1996).PubMedCrossRefGoogle Scholar
  6. Alvarez, E., Northwood, I. C., Gonzalez, F. A., Latour, D. A., Seth, A., Abate, C., Curran, T. and Davis, R. J., Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c- myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase.J Biol Chem, 266, 15277–15285 (1991).PubMedGoogle Scholar
  7. Ashkenazi, A. and Dixit, V. M., Death receptors: signaling and modulation.Science, 281, 1305–1308 (1998).PubMedCrossRefGoogle Scholar
  8. Batzinger, R. P., Ou, S. Y. and Bueding, E., Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents.Cancer Res, 38, 4478–4485 (1978).PubMedGoogle Scholar
  9. Benson, A. M., Barretto, P. B. and Stanley, J. S., Induction of DT-diaphorase by anticarcinogenic sulfur compounds in mice.J Natl Cancer Inst, 76, 467–473 (1986).PubMedGoogle Scholar
  10. Benson, A. M., Batzinger, R. P., Ou, S. Y., Bueding, E., Cha, Y. N. and Talalay, P., Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites, of benzo(a)pyrene by dietary antioxidants.Cancer Res, 38, 4486–4495 (1978).PubMedGoogle Scholar
  11. Bogaards, J. J., van Ommen, B., Falke, H. E., Willems, M. I. and van Bladeren, P. J., Glutathione S-transferase subunit induction patterns of Brussels sprouts, allyl isothiocyanate and goitrin in rat liver and small intestinal mucosa: a new approach for the identification of inducing xenobiotics.Food Chem Toxicol, 28, 81–88 (1990).PubMedCrossRefGoogle Scholar
  12. Brewster, J. L., de Valoir, T., Dwyer, N. D., Winter, E. and Gustin, M. C. An osmosensing signal transduction pathway in yeast.Science, 259, 1760–1763 (1993).PubMedCrossRefGoogle Scholar
  13. Briehl, M. M. and Baker, A. F., Modulation of the antioxidant defense as a factor in apoptosis.Cell Death and Differentiation, 3, 63–70 (1996).PubMedGoogle Scholar
  14. Buetler, T. M., Gallagher, E. P., Wang, C., Stahl, D. L., Hayes, J. D. and Eaton, D. L., Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.Toxicol Appl Pharmacol, 135, 45–57 (1995).PubMedCrossRefGoogle Scholar
  15. Burgering, B. M. and Bos, J. L., Regulation of Ras-mediated signalling: more than one way to skin a cat.Trends Biochem Sci, 20, 18–22 (1995).PubMedCrossRefGoogle Scholar
  16. Busciglio, J. and Yankner, B. A., Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro.Nature, 378, 776–779 (1995).PubMedCrossRefGoogle Scholar
  17. Buttke, T. M. and Sandstrom, P. A., Oxidative stress as a mediator of apoptosis [see comments].Immunol Today, 15, 7–10 (1994).PubMedCrossRefGoogle Scholar
  18. Cano, E., Hazzalin, C. A. and Mahadevan, L. C., Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and −2 are implicated in the induction of c-fos and c-jun.Mol Cell Biol, 14, 7352–7362 (1994).PubMedGoogle Scholar
  19. Cano, E. and Mahadevan, L. C., Parallel signal processing among mammalian MAPKs.Trends Biochem Sci, 20, 117–122 (1995).PubMedCrossRefGoogle Scholar
  20. Castillo, M. H., Perkins, E., Campbell, J. H., Doerr, R., Hassett, J. M., Kandaswami, C. and Middleton, E., Jr., The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin.Am J Surg, 158, 351–355 (1989).PubMedCrossRefGoogle Scholar
  21. Cha, Y. N. and Bueding, E., Effects of 2(3)-tert-butyl-4-hydroxyanisole administration on the activities of several hepatic microsomal and cytoplasmic enzymes in mice.Biochem Pharmacol, 28, 1917–1921 (1979).PubMedCrossRefGoogle Scholar
  22. Cha, Y. N. and Heine, H. S., Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats.Cancer Res, 42, 2609–2615 (1982).PubMedGoogle Scholar
  23. Chan, K. and Kan, Y. W., Nrf2 is essential for protection against acute pulmonary injury in mice [In Process Citation].Proc Natl Acad Sci U S A, 96, 12731–12736 [Record as supplied by publisher] (1999).PubMedCrossRefGoogle Scholar
  24. Chen, Y. R., Meyer, C. F. and Tan, T. H., Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis.J Biol Chem, 271, 631–634 (1996a).PubMedCrossRefGoogle Scholar
  25. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J. and Tan, T. H., The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation.J Biol Chem, 271, 31929–31936 (1996b).PubMedCrossRefGoogle Scholar
  26. Chinnaiyan, A. M., K, O. R., Lane, B. R. and Dixit, V. M., Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death [see comments].Science, 275, 1122–1126 (1997).PubMedCrossRefGoogle Scholar
  27. Choi, H. S. and Moore, D. D., Induction of c-fos and c-jun gene expression by phenolic antioxidants.Mol Endocrinol, 7, 1596–1602 (1993).PubMedCrossRefGoogle Scholar
  28. Clayson, D. B., Iverson, F., Nera, E. A. and Lok, E., The significance of induced forestomach tumors.Annu Rev Pharmacol Toxicol, 30, 441–463 (1990).PubMedCrossRefGoogle Scholar
  29. Cobb, M. H. and Goldsmith, E. J., How MAP kinases are regulated.J Biol Chem, 270 14843–14846 (1995).PubMedCrossRefGoogle Scholar
  30. Conney, A. H., Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.Cancer Res, 42, 4875–4917 (1982).PubMedGoogle Scholar
  31. Crowell, P. L., Prevention and therapy of cancer by dietary monoterpenes.J Nutr, 129, 775S-778S (1999).PubMedGoogle Scholar
  32. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T. and Traganos, F., Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).Cytometry, 27, 1–20 (1997).PubMedCrossRefGoogle Scholar
  33. De Long, M. J., Prochaska, H. J. and Talalay, P., Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols.Cancer Res, 45, 546–551 (1985).PubMedGoogle Scholar
  34. Delia, D., Aiello, A., Lombardi, L., Pelicci, P. G., Grignani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U. andet al., N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.Cancer Res, 53, 6036–6041 (1993).PubMedGoogle Scholar
  35. Derijard, B., Raingeaud, J., Barrett, T., Wu, I. H., Han, J., Ulevitch, R. J. and Davis, R. J., Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms [published erratum appears in Science 1995 Jul 7;269(5220):17].Science, 267, 682–685 (1995).PubMedCrossRefGoogle Scholar
  36. Egan, S. E., Giddings, B. W., Brooks, M. W., Buday, L., Sizeland, A. M. and Weinberg, R. A., Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation [see comments].Nature, 363, 45–51 (1993).PubMedCrossRefGoogle Scholar
  37. Favreau, L. V. and Pickett, C. B., Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants.J. Biol Chem, 266, 4556–4561 (1991).PubMedGoogle Scholar
  38. Fei, P., Matwyshyn, G. A., Rushmore, T. H. and Kong, A. N. T., Transcription regulation of rat glutathione S-transferase Ya subunit gene expression by chemopreventive agents.Pharm Res., 13, 1043–1048 (1996).PubMedCrossRefGoogle Scholar
  39. Fernandes-Alnemri, T., Litwack, G. and Alnemri, E. S., CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.J Biol Chem, 269, 30761–30764 (1994).PubMedGoogle Scholar
  40. Fesus, L., Szondy, Z. and Uray, I., Probing the molecular program of apoptosis by cancer chemopreventive agents.J Cell Biochem Suppl, 22, 151–161 (1995).PubMedCrossRefGoogle Scholar
  41. Freshney, N. W., Rawlinson, L., Guesdon, F., Jones, E., Cowley, S., Husan, J. and Saklatvala, J., Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.Cell, 78, 1039–1049 (1994).PubMedCrossRefGoogle Scholar
  42. Friling, R. S., Bensimon, A., Tichauer, Y. and Daniel, V., Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element.Proc Natl Acad Sci U S A, 87, 6258–6262 (1990).PubMedCrossRefGoogle Scholar
  43. Fuijta, Y., Yamane, T., Tanaka, M., Kuwata, K., Okuzumi, J., Takahashi, T., Fujiki, H. and Okuda, T., Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine in mouse duodenum.Jpn J Cancer Res, 80, 503–505 (1989).Google Scholar
  44. Gerhauser, C., You, M., Liu, J., Moriarty, R. M., Hawthorne, M., Mehta, R. G., Moon, R. C. and Pezzuto, J. M., Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes.Cancer Res, 57, 272–278 (1997).PubMedGoogle Scholar
  45. Glatt, H., Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation.Faseb J, 11, 314–321 (1997).PubMedGoogle Scholar
  46. Gonzalez, F. A., Raden, D. L. and Davis, R. J., Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.J. Biol Chem, 266, 22159–22163 (1991).PubMedGoogle Scholar
  47. Green, D. R. and Reed, J. C., Mitochondria and apoptosis.Science, 281, 1309–1312 (1998).PubMedCrossRefGoogle Scholar
  48. Guenthner, T., Epoxide Hydrolase. In Mulder, G., (Eds).Conjugation Reactions in Drug Metabolism. Taylor & Francis, London, pp. 365–404, 1990.Google Scholar
  49. Guo, Z., Smith, T. J., Wang, E., Eklind, K. I., Chung, F. L. and Yang, C. S., Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice.Carcinogenesis, 14, 1167–1173 (1993).PubMedCrossRefGoogle Scholar
  50. Guo, Z., Smith, T. J., Wang, E., Sadrieh, N., Ma, Q., Thomas, P. E. and Yang, C. S., Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats.Carcinogenesis, 13, 2205–2210 (1992).PubMedCrossRefGoogle Scholar
  51. Han, J., Lee, J. D., Bibbs, L. and Ulevitch, R. J., A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.Science, 265, 808–811 (1994).PubMedCrossRefGoogle Scholar
  52. Hecht, S. S., Chemoprevention by isothiocyanates.J Cell Biochem Suppl, 22, 195–209 (1995).PubMedCrossRefGoogle Scholar
  53. Hengstler, J. G., Arand, M., Herrero, M. F. and Oesch, F., Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases, influence on cancer susceptibility.Recent Results Cancer Res, 154, 47–85 (1998).PubMedGoogle Scholar
  54. Hibi, M., Lin, A., Smeal, T., Minden, A. and Karin, M., Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.Genes Dev, 7, 2135–2148 (1993).PubMedCrossRefGoogle Scholar
  55. Hirano, T., Oka, K. and Akiba, M., Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1.Res Commun Chem Pathol Pharmacol, 64, 69–78 (1989).PubMedGoogle Scholar
  56. Igarashi, K., Kataoka, K., Itoh, K., Hayashi, N., Nishizawa, M. and Yamamoto, M., Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins [see comments].Nature, 367, 568–572 (1994).PubMedCrossRefGoogle Scholar
  57. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. and Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.Biochem Biophys Res Commun, 236, 313–322 (1997).PubMedCrossRefGoogle Scholar
  58. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D. and Yamamoto, M., Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.Genes Dev, 13, 76–86 (1999).PubMedCrossRefGoogle Scholar
  59. Jaiswal, A. K., Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression.Pharmacogenetics, 4, 1–10 (1994).PubMedCrossRefGoogle Scholar
  60. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C. and Pezzuto, J. M., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.Science, 275, 218–220 (1997).PubMedCrossRefGoogle Scholar
  61. Jiao, D., Smith, T. J., Yang, C. S., Pittman, B., Desai, D., Amin, S. and Chung, F. L., Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis.Carcinogenesis, 18, 2143–2147 (1997).PubMedCrossRefGoogle Scholar
  62. Karin, M., The regulation of AP-1 activity by mitogenactivated protein kinases.J Biol Chem, 270, 16483–16486 (1995).PubMedGoogle Scholar
  63. Karin, M., Mitogen-activated protein kinase cascades as regulators of stress responses.Ann N Y Acad Sci, 851, 139–146 (1998).PubMedCrossRefGoogle Scholar
  64. Kashfi, K., Yang, E. K., Chowdhury, J. R., Chowdhury, N. R. and Dannenberg, A. J., Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants.Cancer Res, 54, 5856–5859 (1994).PubMedGoogle Scholar
  65. Kataoka, K., Noda, M. and Nishizawa, M., Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun.Mol Cell Biol, 14, 700–712 (1994).PubMedGoogle Scholar
  66. Katiyar, S. K., Agarwal, R. and Mukhtar, H., Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea.Cancer Res, 53, 5409–5412 (1993).PubMedGoogle Scholar
  67. Kelloff, G. J., Boone, C. W., Steele, V. E., Crowell, J. A., Lubet, R. A., Greenwald, P., Hawk, E. T., Fay, J. R. and Sigman, C. C., Mechanistic considerations in the evaluation of chemopreventive data.IARC Sci Publ, 203–219 (1996).Google Scholar
  68. Kensler, T. W., Egner, P. A., Dolan, P. M., Groopman, J. D. and Roebuck, B. D., Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.Cancer Res, 47, 4271–4277 (1987).PubMedGoogle Scholar
  69. Kensler, T. W., Groopman, J. D., Eaton, D. L., Curphey, T. J. and Roebuck, B. D., Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.Carcinogenesis, 13, 95–100 (1992).PubMedCrossRefGoogle Scholar
  70. Kim, N. D. and Kim, S. G., Chemopreventive effects of 2-(allylthio)pyrazine.Arch Pharm Res, 22, 99–107 (1999).PubMedCrossRefGoogle Scholar
  71. King, M. M. and McCay, P. B., Modulation of tumor incidence and possible mechanisms of inhibition of mammary carcinogenesis by dietary antioxidants.Cancer Res, 43, 2485s-2490s (1983).PubMedGoogle Scholar
  72. Kirlin, W. G., Cai, J., DeLong, M. J., Patten, E. J. and Jones, D. P., Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon carcinoma cells.J Nutr, 129, 1827–1835 (1999).PubMedGoogle Scholar
  73. Kitchen, I., Tremblay, J., Andre, J., Dring, L. G., Idle, J. R., Smith, R. L. and Williams, R. T., Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine.Xenobiotica, 9, 397–404 (1979).PubMedCrossRefGoogle Scholar
  74. Kluck, R. M., Bossy-Wetzel, E., Green, D. R. and Newmeyer, D. D., The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis [see comments].Science, 275, 1132–1136 (1997).PubMedCrossRefGoogle Scholar
  75. Kyriakis, J. M. and Avruch, J., Protein kinase cascades activated by stress and inflammatory cytokines.Bioessays, 18, 567–577 (1996).PubMedCrossRefGoogle Scholar
  76. Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J. and Woodgett, J. R., The stress-activated protein kinase subfamily of c-Jun kinases.Nature, 369, 156–160 (1994).PubMedCrossRefGoogle Scholar
  77. Lam, L. K., Fladmoe, A. V., Hochalter, J. B. and Wattenberg, L. W., Short time interval effects of butylated hydroxyanisole on the metabolism of benzo(a)pyrene.Cancer Res, 40, 2824–2828 (1980).PubMedGoogle Scholar
  78. Langman, M. and Boyle, P., Chemoprevention of colorectal cancer.Gut, 43, 578–585 (1998).PubMedCrossRefGoogle Scholar
  79. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., Landvatter, S. W. and et al., A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.Nature, 372, 739–746 (1994).PubMedCrossRefGoogle Scholar
  80. Lei, W., Yu, R., Mandlekar, S. and Kong, A. N., Induction of apoptosis and activation of interleukin 1beta-converting enzyme/Ced-3 protease (caspase-3) and c-Jun NH2-terminal kinase 1 by benzo(a)pyrene.Cancer Res, 58, 2102–2106 (1998).PubMedGoogle Scholar
  81. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S. and Wang, X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.Cell, 91, 479–489 (1997).PubMedCrossRefGoogle Scholar
  82. Li, Y. and Jaiswal, A. K., Regulation of human NAD (P)H: quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element [published erratum appears in J Biol Chem 1993 Oct 5;268(28):21454].J Biol Chem, 267, 15097–15104 (1992).PubMedGoogle Scholar
  83. Lin, J. K., Liang, Y. C. and Lin-Shiau, S. Y., Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade.Biochem Pharmacol, 58, 911–915 (1999).PubMedCrossRefGoogle Scholar
  84. Liu, X., Zou, H., Slaughter, C. and Wang, X., DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.Cell, 89, 175–184 (1997).PubMedCrossRefGoogle Scholar
  85. Lotan, R., Retinoids in cancer chemoprevention.Faseb J, 10, 1031–1039 (1996).PubMedGoogle Scholar
  86. Lupulescu, A. P., Hormones, vitamins, and growth factors in cancer treatment and prevention. A critical appraisal.Cancer, 78, 2264–2280 (1996).PubMedCrossRefGoogle Scholar
  87. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D. W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Chowdhury, J. R., Ritter, J. K., Schachter, H., Tephly, T. R., Tipton, K. F. and Nebert, D. W., The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.Pharmacogenetics, 7, 255–269 (1997).PubMedCrossRefGoogle Scholar
  88. Marshall, C. J., MAP kinase kinase kinase, MAP kinase kinase and MAP kinase.Curr Opin Genet Dev, 4, 82–89 (1994).PubMedCrossRefGoogle Scholar
  89. Martin, S. J. and Green, D. R., Protease activation during apoptosis: death by a thousand cuts?Cell, 82, 349–352 (1995).PubMedCrossRefGoogle Scholar
  90. McGowan, A. J., Ruiz-Ruiz, M. C., Gorman, A. M., Lopez-Rivas, A. and Cotter, T. G., Reactive oxygen intermediate(s) (ROI): common mediator(s) of poly (ADP-ribose)polymerase (PARP) cleavage and apoptosis.FEBS Lett, 392, 299–303 (1996).PubMedCrossRefGoogle Scholar
  91. Mizutani, T., Nomura, H., Nakanishi, K. and Fujita, S., Hepatotoxicity of butylated hydroxytoluene and its analogs in mice depleted of hepatic glutathione.Toxicol Appl Pharmacol, 87, 166–176 (1987).PubMedCrossRefGoogle Scholar
  92. Moi, P., Chan, K., Asunis, I., Cao, A. and Kan, Y. W., Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.Proc Natl Acad Sci U S A, 91, 9926–9930 (1994).PubMedCrossRefGoogle Scholar
  93. Moinova, H. R. and Mulcahy, R. T., Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element.Biochem Biophys Res Commun, 261, 661–668 (1999).PubMedCrossRefGoogle Scholar
  94. Mulder, G., Coughtrie, MWH, and Burchell, B., Glucuronidation. In GJ, M., (Eds).Conjugation Reactions in Drug Metabolism. Taylor & Francis, London, pp. 51–106, 1990.Google Scholar
  95. Munzel, P. A., Schmohl, S., Heel, H., Kalberer, K., Bock-Hennig, B. S. and Bock, K. W., Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells.Drug Metab Dispos, 27, 569–573 (1999).PubMedGoogle Scholar
  96. Nagata, S., Apoptosis by death factor.Cell, 88, 355–365 (1997).PubMedCrossRefGoogle Scholar
  97. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O. and et al., The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.DNA Cell Biol, 12, 1–51 (1993).PubMedGoogle Scholar
  98. Okuda, A., Imagawa, M., Maeda, Y., Sakai, M. and Muramatsu, M., Structural and functional analysis of an enhancer GPEI having a phorbol 12-O-tetradecanoate 13-acetate responsive element-like sequence found in the rat glutathione transferase P gene.J Biol Chem, 264, 16919–16926 (1989).PubMedGoogle Scholar
  99. Pascale, R. M., Marras, V., Simile, M. M., Daino, L., Pinna, G., Bennati, S., Carta, M., Seddaiu, M. A., Massarelli, G. and Feo, F., Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study.Cancer Res, 52, 4979–4986 (1992).PubMedGoogle Scholar
  100. Patten, E. J. and DeLong, M. J., Temporal effects of the detoxification enzyme inducer, benzyl isothiocyanate: activation of c-jun N-terminal kinase prior to the transcription factors AP-1 and NFkappaB.Biochem Biophys Res Commun, 257, 149–155 (1999).PubMedCrossRefGoogle Scholar
  101. Pezzuto, J.,Cancer chemopreventive agents: from plant materials to clinical intervention trials. American Chemical Society Books, Washington, DC, 1993.Google Scholar
  102. Pezzuto, J.,Natural product cancer chemopreventive agents. Plenum Press, New York, 1995.Google Scholar
  103. Pezzuto, J. M., Plant-derived anticancer agents.Biochem Pharmacol, 53, 121–133 (1997).PubMedCrossRefGoogle Scholar
  104. Pinkus, R., Weiner, L. M. and Daniel, V., Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression.J Biol Chem, 271, 13422–13429 (1996).PubMedCrossRefGoogle Scholar
  105. Prestera, T., Holtzclaw, W. D., Zhang, Y. and Talalay, P., Chemical and molecular regulation of enzymes that detoxify carcinogens.Proc Natl Acad Sci U S A, 90, 2965–2969 (1993).PubMedCrossRefGoogle Scholar
  106. Prochaska, H. J. and Talalay, P., Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver.Cancer Res, 48, 4776–4782 (1988).PubMedGoogle Scholar
  107. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J. and Davis, R. J., Pro-inflammatory cytokines and environmental stress cause p38 mitogenactivated protein kinase activation by dual phosphorylation on tyrosine and threonine.J Biol Chem, 270, 7420–7426 (1995).PubMedCrossRefGoogle Scholar
  108. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T. and Nebreda, A. R., A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.Cell, 78, 1027–1037 (1994).PubMedCrossRefGoogle Scholar
  109. Rushmore, T., Pickett, CB, and Lu AYH.,Regulation fo expression of rat liver glutathione S-transferases: Xenobiotic and antioxidant induction of the Ya subunit gene. Springer-Verlag, Berlin Heidelberg, 1994.Google Scholar
  110. Rushmore, T. H., Morton, M. R. and Pickett, C. B., The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity.J Biol Chem, 266, 11632–11639 (1991).PubMedGoogle Scholar
  111. Rushmore, T. H. and Pickett, C. B., Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants.J Biol Chem, 265, 14648–14653 (1990).PubMedGoogle Scholar
  112. Samaha, H. S., Kelloff, G. J., Steele, V., Rao, C. V. and Reddy, B. S., Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.Cancer Res, 57, 1301–1305 (1997).PubMedGoogle Scholar
  113. Shao, Z. M., Wu, J., Shen, Z. Z. and Barsky, S. H., Genistein exerts multiple suppressive effects on human breast carcinoma cells.Cancer Res, 58, 4851–4857 (1998).PubMedGoogle Scholar
  114. Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J., Jr., Backer, J. M., Ullrich, A., White, M. F. and et al., The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.Embo J, 12, 1929–1936 (1993).PubMedGoogle Scholar
  115. Slater, A., Stefan, C, Nobel, I, Van Den Dobbelsteen, DJ, and Orrenius, S., Intracellular redox changes during apoptosis.Cell Death and Differentiation, 3, 57–62 (1996).PubMedGoogle Scholar
  116. Smith, C. A., Farrah, T. and Goodwin, R. G., The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.Cell, 76, 959–962 (1994).PubMedCrossRefGoogle Scholar
  117. Sparnins, V. L., Chuan, J. and Wattenberg, L. W., Enhancement of glutathione S-transferase activity of the esophagus by phenols, lactones, and benzyl isothiocyanate.Cancer Res, 42, 1205–1207 (1982a).PubMedGoogle Scholar
  118. Sparnins, V. L., Venegas, P. L. and Wattenberg, L. W., Glutathione S-transferase activity: enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents.J Natl Cancer Inst, 68, 493–496 (1982b).PubMedGoogle Scholar
  119. Steller, H., Mechanisms and genes of cellular suicide.Science, 267, 1445–1449 (1995).PubMedCrossRefGoogle Scholar
  120. Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M. and Hancock, J. F., Activation of Raf as a result of recruitment to the plasma membrane [see comments] [published erratum appears in Science 1994 Dec 16;266(5192):1792-3].Science, 264, 1463–1467 (1994).PubMedCrossRefGoogle Scholar
  121. Stoner, G. D., Morrissey, D. T., Heur, Y. H., Daniel, E. M., Galati, A. J. and Wagner, S. A., Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus.Cancer Res, 51, 2063–2068 (1991).PubMedGoogle Scholar
  122. Talalay, P., De Long, M.J., and Prochaska, H.J.,Molecular Mechanisms in protection against carcinogenesis. Plenum, New York, 1987.Google Scholar
  123. Talalay, P., Mechanisms of induction of enzymes that protect against chemical carcinogenesis.Adv Enzyme Regul, 28, 237–250 (1989).PubMedCrossRefGoogle Scholar
  124. Tartaglia, L. A., Rothe, M., Hu, Y. F. and Goeddel, D. V., Tumor necrosis factor’s cytotoxic activity is signaled by the p55 TNF receptor.Cell, 73, 213–216 (1993).PubMedCrossRefGoogle Scholar
  125. Tewari, M., Quan, L. T., K, O. R., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M., Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.Cell, 81, 801–809 (1995).PubMedCrossRefGoogle Scholar
  126. Thompson, C. B., Apoptosis in the pathogenesis and treatment of disease.Science, 267, 1456–1462 (1995).PubMedCrossRefGoogle Scholar
  127. Thornberry, N. A. and Lazebnik, Y., Caspases: enemies within.Science, 281, 1312–1316 (1998).PubMedCrossRefGoogle Scholar
  128. Ulland, B. M., Weisburger, J. H., Yamamoto, R. S. and Weisburger, E. K., Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats.Food Cosmet Toxicol, 11, 199–207 (1973).PubMedCrossRefGoogle Scholar
  129. Venugopal, R. and Jaiswal, A. K., Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.Proc Natl Acad Sci U S A, 93, 14960–14965 (1996).PubMedCrossRefGoogle Scholar
  130. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z. and Kolesnick, R. N., Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.Nature, 380, 75–79 (1996).PubMedCrossRefGoogle Scholar
  131. Wang, X. S., Diener, K., Manthey, C. L., Wang, S., Rosenzweig, B., Bray, J., Delaney, J., Cole, C. N., Chan-Hui, P.Y., Mantlo, N., Lichenstein, H. S., Zukowski, M. and Yao, Z., Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase.J Biol Chem, 272, 23668–23674 (1997).PubMedCrossRefGoogle Scholar
  132. Wang, Z. Y., Cheng, S. J., Zhou, Z. C., Athar, M., Khan, W. A., Bickers, D. R. and Mukhtar, H., Antimutagenic activity of green tea polyphenols.Mutat Res, 223, 273–285 (1989).PubMedCrossRefGoogle Scholar
  133. Wang, Z. Y., Huang, M. T., Lou, Y. R., Xie, J. G., Reuhl, K. R., Newmark, H. L., Ho, C. T., Yang, C. S. and Conney, A. H., Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice.Cancer Res, 54, 3428–3435 (1994).PubMedGoogle Scholar
  134. Wasserman, W. W. and Fahl, W. E., Functional antioxidant responsive elements.Proc Natl Acad Sci U S A, 94, 5361–5366 (1997).PubMedCrossRefGoogle Scholar
  135. Wattenberg, L. W., Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole.J Natl Cancer Inst, 50, 1541–1544 (1973).PubMedGoogle Scholar
  136. Wattenberg, L. W., Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds.J. Natl Cancer Inst, 58, 395–398 (1977).PubMedGoogle Scholar
  137. Wattenberg, L. W., Inhibition of neoplasia by minor dietary constituents.Cancer Res, 43, 2448s-2453s. (1983).PubMedGoogle Scholar
  138. Wattenberg, L. W., Chemoprevention of cancer.Cancer Res, 45, 1–8 (1985).PubMedCrossRefGoogle Scholar
  139. Wattenberg, L. W., Protective effects of 2(3)-tert-butyl-4-hydroxyanisole on chemical carcinogenesis.Food Chem Toxicol, 24, 1099–1102 (1986).PubMedCrossRefGoogle Scholar
  140. Wattenberg, L. W., Prevention-therapy-basic science and the resolution of the cancer problem.Cancer Res, 53, 5890–5896 (1993).PubMedGoogle Scholar
  141. Wattenberg, L. W. and Bueding, E., Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethyl-nitrosamine and uracil mustard.Carcinogenesis, 7, 1379–1381 (1986).PubMedCrossRefGoogle Scholar
  142. Wattenberg, L. W., Coccia, J. B. and Lam, L. K., Inhibitory effects of phenolic compounds on benzo(a)pyrene-induced neoplasia.Cancer Res, 40, 2820–2823 (1980).PubMedGoogle Scholar
  143. Wattenberg, L. W., Lam, L. K., Fladmoe, A. V. and Borchert, P., Inhibits of of colon carcinogenesis.Cancer, 40, 2432–2435 (1977).PubMedCrossRefGoogle Scholar
  144. Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C. and Raftogianis, R. B., Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.Faseb J, 11, 3–14 (1997).PubMedGoogle Scholar
  145. Weinstein, I. B., Begemann, M., Zhou, P., Han, E. K., Sgambato, A., Doki, Y., Arber, N., Ciaparrone, M. and Yamamoto, H., Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy.Clin Cancer Res, 3, 2696–2702 (1997).PubMedGoogle Scholar
  146. Weisburger, E. K. and Evarts, R. P., Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane.Food Cosmet Toxicol, 15, 139–141 (1977).PubMedCrossRefGoogle Scholar
  147. Williams, R. T., Species variations in the pathways of drug metabolism.Environ Health Perspect, 22, 133–138 (1978).PubMedCrossRefGoogle Scholar
  148. Wormhoudt, L. W., Commandeur, J. N. and Vermeulen, N. P., Genetic polymorphisms of human N-acetyl-transferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.Crit Rev Toxicol, 29, 59–124 (1999).PubMedCrossRefGoogle Scholar
  149. Xu, Y., Ho, C. T., Amin, S. G., Han, C. and Chung, F. L., Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants.Cancer Res, 52, 3875–3879 (1992).PubMedGoogle Scholar
  150. Yan, Y. S., [Effect of Chinese green tea extracts on the human gastric carcinoma cell in vitro].Chung Hua Yu Fang I Hsueh Tsa Chih, 24, 80–82 (1990).PubMedGoogle Scholar
  151. Yang, C. S., Brady, J. F. and Hong, J. Y., Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity.Faseb J, 6, 737–744 (1992).PubMedGoogle Scholar
  152. Yang, C. S., Smith, T. J. and Hong, J. Y., Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations.Cancer Res, 54, 1982s-1986s (1994).PubMedGoogle Scholar
  153. Yang, C. S. and Wang, Z. Y., Tea and cancer.J Natl Cancer Inst, 85, 1038–1049 (1993).PubMedCrossRefGoogle Scholar
  154. Yang, G. Y., Liao, J., Kim, K., Yurkow, E. J. and Yang, C. S., Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols.Carcinogenesis, 19, 611–616 (1998).PubMedCrossRefGoogle Scholar
  155. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P. and Wang, X., Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked [see comments].Science, 275, 1129–1132 (1997).PubMedCrossRefGoogle Scholar
  156. Ye, H., Kelly, T. F., Samadani, U., Lim, L., Rubio, S., Overdier, D. G., Roebuck, K. A. and Costa, R. H., Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues.Mol Cell Biol, 17, 1626–1641 (1997).PubMedGoogle Scholar
  157. Yu, R., Mandlekar, S., Harvey, K.J., Ucker, D.S., and Kong, A.-N. T., Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity.Cancer Res., 58, 402–408 (1998a).PubMedGoogle Scholar
  158. Yu, R., Mandlekar, S., and Kong, A.-N.T., Distinct roles of intracellular calcium in the activation of c-jun N-terminal kinases and caspases during apoptosis induced by phenolic antioxidant BHA. In37th Annual Meeting of Society of Toxicology, Seattle, WA, Toxicological Sciences (Formerly Fund. Appl. Tox.). pp. 356. Seattle, WA (1998b).Google Scholar
  159. Yu, R., Mandlekar, S., Lei, W., Fahl, W.E., Tan, T.-H., and Kong, A.-N.T., p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug metabolizing enzymes that detoxify carcinogens.J. Biol. Chem., 275 (February 2000 (in the press)).Google Scholar
  160. Yu, R., Jiao, J. J., Duh, J. L., Gudehithlu, K., Tan, T. H. and Kong, A. N. T., Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression.Carcinogenesis, 18, 451–456 (1997a).PubMedCrossRefGoogle Scholar
  161. Yu, R., Jiao, J. J., Duh, J. L., Tan, T. H. and Kong, A. N. T., Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1.Cancer Res, 56, 2954–2959 (1996a).PubMedGoogle Scholar
  162. Yu, R., Lei, W., Mandlekar, S., Weber, M. J., Der, C. J., Wu, J. and Kong, A. T., Role of a Mitogen-activated Protein Kinase Pathway in the Induction of Phase II Detoxifying Enzymes by Chemicals.J Biol Chem, 274, 27545–27552 (1999).PubMedCrossRefGoogle Scholar
  163. Yu, R., Shtil, A. A., Tan, T. H., Roninson, I. B. and Kong, A. N. T., Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis.Cancer Lett, 107, 73–81 (1996b).PubMedCrossRefGoogle Scholar
  164. Yu, R., Tan, T. H. and Kong, A. T., Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants.J Biol Chem, 272, 28962–28970 (1997b).PubMedCrossRefGoogle Scholar
  165. Zhang, Y., Kolm, R. H., Mannervik, B. and Talalay, P., Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases.Biochem Biophys Res Commun, 206, 748–755 (1995).PubMedCrossRefGoogle Scholar
  166. Zhang, Y. and Talalay, P., Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms.Cancer Res., 54, 1976s-1981s (1994).PubMedGoogle Scholar
  167. Zhang, Y., Talalay, P., Cho, C. G. and Posner, G. H., A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure.Proc Natl Acad Sci U S A, 89, 2399–2403 (1992).PubMedCrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 1999

Authors and Affiliations

  • Ah-Ng Tony Kong
    • 1
  • Rong Yu
    • 1
  • Chi Chen
    • 1
  • Sandhya Mandlekar
    • 1
  • Thomas Primiano
    • 2
  1. 1.Center for Pharmaceutical Biotechnology, MC 870 Department of Pharmaceutics and Pharmacodynamics, College of PharmacyUniversity of Illinois at ChicagoChicagoUSA
  2. 2.Department of Molecular Genetics, College of MedicineUniversity of Illinois at ChicagoChicagoUSA

Personalised recommendations